S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
MRMD · MariMed Inc.
OTC MARKETS - Real Time Price • USD
$0.06
-0.00
(-2.63%)
● Overnight
DAY'S RANGE
$0.06
$0.05
$0.06
52-WEEK RANGE
$0.06
$0.06
$0.18
What's happening
- MRMD is down 2.63% today, trading at $0.06. — Live quote
- It's trading within 3% of its 52-week low ($0.06). (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.01 actual vs. $-0.01 estimated (+2.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 4
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-09-01 (8 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
MRMD
-36.17%
vs S&P 500
-49.03%
1-YEAR RETURN
MRMD
-62.73%
vs S&P 500
-78.95%
6-MONTH RETURN
MRMD
-14.16%
3-MONTH RETURN
MRMD
-9.09%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.01
Est. $-0.01
BEAT +2.0%
2026-04-26 (Q1 2026)
$-0.01
Est. $-0.01
BEAT +2.0%
2026-01-26 (Q4 2025)
$-0.01
Est. $-0.01
BEAT +2.0%
2025-10-26 (Q3 2025)
$-0.01
Est. $-0.01
BEAT +2.0%
Valuation Measures & Ratios
Enterprise Value4$98.0M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)0.15
Price / Book70.54
EV4 / Revenue0.60
EV4 / EBITDA14.02
Profit Margin-9.13%
Operating Margin-1.03%
Return on Equity (ROE8)-25.14%
Return on Assets (ROA9)-7.42%
Avg Volume (3M)500,600
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short1,000
Change from Prior Settlement-97.76%
% of Float—
Days to Cover (Short Ratio)1.00
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 5.8% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-15; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -9.1%. Finnhub fundamentals ↗
- Trailing 52-week price return is -62.7%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on MRMD
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $41.9M | $39.5M | $40.8M | $39.5M | $37.9M | $40.6M | $40.4M | $37.9M |
| Gross profit | $16.2M | $15.3M | $16.4M | $15.9M | $15.1M | $16.8M | $16.9M | $16.5M |
| Operating income | $418.0K | $125.0K | $1.6M | $1.0M | -$910.0K | $1.3M | $956.0K | $2.0M |
| Net income | -$3.6M | -$3.8M | -$2.9M | -$1.4M | -$5.5M | -$1.0M | -$1.7M | -$1.3M |
| EPS (diluted) | $-0.01 | $-0.01 | $-0.01 | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 |
| EPS (basic) | $-0.01 | $-0.01 | $-0.01 | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 |
| Operating margin | $1 | $0 | $4 | $3 | -$2 | $3 | $2 | $5 |
| Net margin | -$9 | -$10 | -$7 | -$4 | -$15 | -$2 | -$4 | -$3 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $197.2M | $201.2M | $202.6M | $205.6M | $204.4M | $208.0M | $207.0M | $212.7M |
| Total liabilities | $147.1M | $147.7M | $137.8M | $136.6M | $131.2M | $134.1M | $129.4M | $125.8M |
| Stockholders' equity | — | — | — | — | — | — | — | — |
| Total current assets | $58.4M | $60.8M | $59.3M | $60.1M | $57.1M | $58.0M | $53.5M | $56.7M |
| Total current liabilities | $63.8M | $63.8M | $59.1M | $56.6M | $50.9M | $55.3M | $50.0M | $44.6M |
| Cash & equivalents | — | — | — | $6.6M | $6.1M | $7.2M | $7.3M | $9.8M |
| Marketable securities (current) | — | — | — | — | — | — | $0 | $0 |
| Accounts receivable | $9.4M | $9.4M | $9.1M | $8.0M | $7.7M | $9.2M | $8.7M | $7.3M |
| Inventory | $36.7M | $39.3M | $36.6M | $40.0M | $38.8M | $37.6M | $33.5M | $35.0M |
| Other current assets | $4.0M | $3.2M | $3.8M | $4.6M | $4.4M | $4.0M | $3.4M | $3.7M |
| Marketable securities (non-current) | — | — | — | — | — | — | $0 | $0 |
| Property, plant & equipment | $86.4M | $88.1M | $89.4M | $91.3M | $92.6M | $94.4M | $94.2M | $95.5M |
| Goodwill | $24.0M | $24.0M | $24.0M | $22.7M | $20.1M | $19.5M | $15.8M | $15.8M |
| Intangible assets | $15.7M | $16.4M | $17.2M | $18.0M | $20.7M | $21.7M | $18.6M | $19.5M |
| Other non-current assets | $929.0K | $950.0K | $931.0K | $1.1M | $1.1M | $1.1M | $11.2M | $11.1M |
| Accounts payable | $13.1M | $15.1M | $14.6M | $11.2M | $11.2M | $14.0M | $13.2M | $13.0M |
| Accrued liabilities | $10.0M | $10.4M | $9.5M | $9.0M | $7.4M | $7.7M | $4.4M | $6.3M |
| Deferred revenue (current) | $1.7M | $1.5M | $1.4M | $1.7M | — | — | $1.3M | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | $82.7M | $82.5M | $76.0M | $76.2M | $77.5M | $77.4M | $78.2M | $79.4M |
| Other non-current liabilities | — | — | $0 | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K |
| Common stock & paid-in capital | $401.0K | $399.0K | $397.0K | $394.0K | $392.0K | $389.0K | $381.0K | $381.0K |
| Retained earnings | -$135.3M | -$131.7M | -$127.9M | -$123.3M | -$118.8M | -$117.6M | -$113.4M | -$103.9M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.2M | $949.0K | $3.4M | $2.7M | $297.0K | $1.3M | -$413.0K | $803.0K |
| Investing cash flow | -$507.0K | -$753.0K | -$197.0K | -$514.0K | -$554.0K | -$115.0K | -$1.2M | -$2.1M |
| Financing cash flow | -$1.2M | -$1.1M | -$944.0K | -$1.7M | -$806.0K | -$1.3M | -$893.0K | $917.0K |
| Free cash flow | $1.9M | $576.0K | $3.4M | $2.1M | -$12.0K | $1.0M | -$1.5M | -$1.8M |
| Capital expenditures | $298.0K | $373.0K | $33.0K | $559.0K | $309.0K | $266.0K | $1.1M | $2.6M |
| Share-based compensation | $350.0K | $325.0K | $382.0K | $382.0K | $549.0K | $547.0K | $278.0K | $280.0K |
| Deferred income taxes | — | — | $0 | — | — | — | $0 | — |
| Change in accounts receivable | $629.0K | $401.0K | $1.4M | $328.0K | -$1.6M | $303.0K | $1.2M | -$539.0K |
| Change in inventory | -$2.6M | $2.7M | -$2.9M | $1.2M | $1.3M | $453.0K | -$1.5M | $3.8M |
| Change in accounts payable | -$2.0M | $523.0K | $3.5M | $23.0K | -$2.8M | $86.0K | -$32.0K | $613.0K |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $159.8M | $157.7M | $148.6M | $134.0M | $121.5M |
| Gross profit | $57.9M | $62.6M | $65.9M | $64.0M | $66.3M |
| Operating income | -$2.8M | $2.6M | $14.4M | $20.4M | $26.9M |
| Net income | -$14.5M | -$12.5M | -$16.0M | $13.5M | $7.2M |
| EPS (diluted) | $-0.04 | $-0.03 | $-0.04 | $0.04 | $0.02 |
| EPS (basic) | $-0.04 | $-0.03 | $-0.04 | $0.04 | $0.02 |
| Operating margin | -$2 | $2 | $10 | $15 | $22 |
| Net margin | -$9 | -$8 | -$11 | $10 | $6 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $202.6M | $207.0M | $196.1M | $152.2M | $123.2M |
| Total liabilities | $137.8M | $129.4M | $107.2M | $57.2M | $49.2M |
| Stockholders' equity | — | — | — | — | — |
| Total current assets | $59.3M | $53.5M | $51.4M | $44.1M | $44.6M |
| Total current liabilities | $59.1M | $50.0M | $30.9M | $26.5M | $27.2M |
| Cash & equivalents | — | $7.3M | $14.6M | $9.7M | $29.7M |
| Marketable securities (current) | — | $0 | $88.0K | $123.0K | $251.0K |
| Accounts receivable | $9.1M | $8.7M | $7.2M | $4.2M | $1.7M |
| Inventory | $36.6M | $33.5M | $25.3M | $19.5M | $9.8M |
| Other current assets | $3.8M | $3.4M | $3.5M | $7.3M | $1.4M |
| Marketable securities (non-current) | — | $0 | $221.0K | $0 | $0 |
| Property, plant & equipment | $89.4M | $94.2M | $89.1M | $71.6M | $62.1M |
| Goodwill | $24.0M | $15.8M | $12.0M | $8.1M | $2.1M |
| Intangible assets | $17.2M | $18.6M | $17.0M | $14.2M | $162.0K |
| Other non-current assets | $931.0K | $11.2M | $12.5M | $1.0M | $98.0K |
| Accounts payable | $14.6M | $13.2M | $9.0M | $6.6M | $5.1M |
| Accrued liabilities | $9.5M | $4.4M | $3.5M | $3.1M | $3.1M |
| Deferred revenue (current) | $1.4M | $1.3M | — | — | — |
| Other current liabilities | — | — | — | — | $1.9K |
| Long-term debt | $76.0M | $78.2M | — | — | — |
| Other non-current liabilities | $0 | $100.0K | $100.0K | $100.0K | $100.0K |
| Common stock & paid-in capital | $397.0K | $381.0K | $375.0K | $341.0K | $334.0K |
| Retained earnings | -$127.9M | -$113.4M | -$100.0M | -$83.9M | -$97.4M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $7.7M | $6.8M | $7.9M | $7.3M | $35.9M |
| Investing cash flow | -$1.4M | -$17.1M | -$26.0M | -$26.2M | -$16.6M |
| Financing cash flow | -$4.7M | $3.0M | $23.0M | -$1.0M | $7.5M |
| Free cash flow | $6.5M | -$5.2M | -$12.2M | -$4.8M | $18.0M |
| Capital expenditures | $1.2M | $12.0M | $20.1M | $12.1M | $17.9M |
| Share-based compensation | $1.9M | $1.1M | $1.0M | $6.3M | — |
| Deferred income taxes | $0 | $0 | — | — | — |
| Change in accounts receivable | $429.0K | $1.2M | $3.2M | $6.9M | $4.7M |
| Change in inventory | $6.0K | $8.2M | $5.8M | $5.4M | $2.9M |
| Change in accounts payable | $841.0K | $4.2M | $2.4M | $1.0M | $105.0K |
| Purchases of investments | — | — | — | — | — |
| Other financing activities | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding MRMD as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Insider activity is not available for this symbol right now.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:14 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-15 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-15 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-15 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-15 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-02 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-02 | View on SEC.gov → |
| 2026-09-28 | 4 | 2026-09-28 | View on SEC.gov → |
| 2026-09-23 | 8-K | 2026-09-23 | View on SEC.gov → |
| 2026-09-01 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-12 | 8-K | 2026-08-12 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-15 | View on SEC.gov → |
Recent news
Headlines about MRMD (MariMed Inc.). Links open the publisher — we don’t host full articles.
-
MariMed Inc. Q3FY26 Results: Earnings release set for November 11
scanx.trade · 2026-10-20 -
MariMed Announces Third Quarter 2026 Earnings Date
Yahoo Finance · 2026-10-20 -
Form 4 Marimed Inc: Mario Pinho (CFO) For: 15 October By Investing.com
Investing.com Nigeria · 2026-10-16 -
Form 4 Marimed Inc: Jon R. Levine (Director, 10% Owner, President and CEO) For: 15 October
Investing.com India · 2026-10-15 -
MariMed COO Timothy Shaw Vests 42,657 RSUs and Sells 12,520 Shares for Tax on October 15, 2026
Kalkine Media · 2026-10-15 -
MariMed CCO Ryan Crandall Converts 32,812 RSUs and Withholds 9,631 Shares for Taxes on October 15, 2026
Kalkine Media · 2026-10-15 -
Converting 38,282 stock awards, MariMed (MRMD) CFO had 11,236 shares withheld for taxes.
Stock Titan · 2026-10-15 -
MariMed’s Betty’s Eddies Spreads Importance of Cancer Screening Education and Awareness this October through Partnership with Keep A Breast Foundation
Yahoo Finance · 2026-09-24
No headlines in this category right now — try “All”.